Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection

Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection

<p>Table S1: Patient summary of demographic characteristics and mutation status in individual sets and the combined BC set</p>

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	Nina Rao (15321199) (author)
Beste egile batzuk:	Gabriel J. Starrett (16624138) (author), Mary L. Piaskowski (17079483) (author), Kelly E. Butler (17079486) (author), Yelena Golubeva (17079489) (author), Wusheng Yan (17079492) (author), Scott M. Lawrence (17079495) (author), Michael Dean (14946283) (author), Montserrat Garcia-Closas (15035106) (author), Dalsu Baris (15321208) (author), Alison Johnson (15035103) (author), Molly Schwenn (15321211) (author), Nuria Malats (14943841) (author), Francisco X. Real (15337922) (author), Manolis Kogevinas (13368975) (author), Nathaniel Rothman (15321220) (author), Debra T. Silverman (15321223) (author), Lars Dyrskjøt (15054430) (author), Christopher B. Buck (17079498) (author), Stella Koutros (15035094) (author), Ludmila Prokunina-Olsson (15021962) (author)
Argitaratua:	2025
Gaiak:	Cancer Cancer Biology Cancer Detection and Diagnosis Epidemiology Biomarkers Genetic biomarkers Genitourinary Cancers Bladder cancer Methodology and Modeling Viral Oncogenesis DNA tumor viruses
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak

Table S2 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
nork: Nina Rao (15321199)
Argitaratua: (2025)

Table S3 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
nork: Nina Rao (15321199)
Argitaratua: (2025)

Table S4 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
nork: Nina Rao (15321199)
Argitaratua: (2025)

Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
nork: Nina Rao (15321199)
Argitaratua: (2025)

Table S6 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
nork: Nina Rao (15321199)
Argitaratua: (2025)

Table S7 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
nork: Nina Rao (15321199)
Argitaratua: (2025)

Figure 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
nork: Alba L. Combita (22677298)
Argitaratua: (2025)

Figure 2 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
nork: Alba L. Combita (22677298)
Argitaratua: (2025)

Figure 3 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
nork: Alba L. Combita (22677298)
Argitaratua: (2025)

Figure 4 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
nork: Alba L. Combita (22677298)
Argitaratua: (2025)

Figure 5 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
nork: Alba L. Combita (22677298)
Argitaratua: (2025)

Table 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
nork: Alba L. Combita (22677298)
Argitaratua: (2025)

Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research
nork: Ming Wang (8809334)
Argitaratua: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
nork: Shuwei Li (16437116)
Argitaratua: (2025)

Supplementary Tables from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
nork: Weisi Liu (14963321)
Argitaratua: (2025)

Supplementary Video from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
nork: Weisi Liu (14963321)
Argitaratua: (2025)

Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
nork: Yuan Chun Ding (16721349)
Argitaratua: (2025)

Supplementary Data from Genome-Wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk
nork: Fan Wang (14963418)
Argitaratua: (2025)

Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
nork: Athanasios Bikas (16006076)
Argitaratua: (2025)

Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
nork: Erwei Zeng (14958443)
Argitaratua: (2025)

Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
nork: Erwei Zeng (14958443)
Argitaratua: (2025)

Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
nork: Erwei Zeng (14958443)
Argitaratua: (2025)

Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
nork: Erwei Zeng (14958443)
Argitaratua: (2025)

Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
nork: Erwei Zeng (14958443)
Argitaratua: (2025)

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
nork: Emil Christensen (15054394)
Argitaratua: (2025)

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
nork: Emil Christensen (15054394)
Argitaratua: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
nork: Josephine K. Dermawan (17079555)
Argitaratua: (2025)

Characterization of a Novel Porcine Circovirus Type 2a Sequence and Anti-Viral Evaluation of Matrine and Sanguinarine Combined with Network Pharmacology and Molecular Docking
nork: WENTING Qiao (22587494)
Argitaratua: (2025)

Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
nork: Ismael Fernández-Miranda (15051932)
Argitaratua: (2025)

Supplementary Tables S1-S12 from Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
nork: Achal Patel (5853731)
Argitaratua: (2025)

Figure S1 from Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR
nork: Jeffrey D. Mandell (14963909)
Argitaratua: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
nork: Ruiyun Zhang (17142498)
Argitaratua: (2025)

Supplementary Figure S1 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
nork: Sarita Paudel (15047430)
Argitaratua: (2025)

Supplementary Figure S2 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
nork: Sarita Paudel (15047430)
Argitaratua: (2025)

Supplementary Figure S3 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
nork: Sarita Paudel (15047430)
Argitaratua: (2025)

Supplementary Figure S4 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
nork: Sarita Paudel (15047430)
Argitaratua: (2025)

Supplementary Figure S5 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
nork: Sarita Paudel (15047430)
Argitaratua: (2025)

Supplementary Figure S6 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
nork: Sarita Paudel (15047430)
Argitaratua: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
nork: Leon J. Wils (15055780)
Argitaratua: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
nork: Leon J. Wils (15055780)
Argitaratua: (2025)

Cannot write session to /tmp/vufind_sessions/sess_npuipa5ci7k8b8e42tvfro0qh0